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We agree with the conclusion of Abdi et al., but To the Editor;
We read with keen interest the article "Effects of two types of human cells on outgrowth of human glioma in rats" (1). In this paper, Abdi et al. reported that: Olfactory ensheathing cells (OECs) and bone marrow stem cells (BMSCs) can pass the blood brain barrier (BBB) and reach the glioma mass. Therefore, this approach can be a potentially powerful method for the delivery of therapeutic agents to malignant brain tumors. In addition, these cells can be genetically modified in order to specifically express tumor-inhibiting factors. In terms of how the transplanted cells penetrated the BBB, different groups have taken different views (2,3,5,6,8), but this strategy really provides a new insight into intracranial lesions and tumors in the future, especially intracranial tumors.
We would like to share our ideas on this topic. Methods to more effectively target agents or transplant cells to target tissues and organs are being developed and include the coating of cells with antibodies or peptides, modifying native cell surface molecules, genetic modification, etc. Because of the existence of the BBB, it is difficult to achieve therapeutic effects for intracranial lesions and/or intracranial tumors with conventional treatment (4, 7, 9) . Menge et al. reported that mesenchymal stem cells (MSCs) may be useful for treating a variety of diseases associated with vascular instability and MSCs regulate BBB integrity through tissue inhibitor of matrix metalloproteinase-3 release after traumatic brain injury (7) . 
